Latest PAREXEL International Corporation Stories

- Service revenue of $454.5 million, up 27.7% year-over-year BOSTON, April 30, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the third quarter of Fiscal Year 2013, which ended on March 31, 2013. For the three months ended March 31, 2013 consolidated service revenue increased by 27.7% to $454.5 million compared with $356.0 million in the prior year period. Excluding the negative impact from foreign exchange...

BOSTON, April 30, 2013 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL), a global clinical research organization, announced that today the Company acquired all of the outstanding equity securities of the HERON Group LTD ("HERON"), a life sciences consultancy which provides evidence-based commercialization services to support biopharmaceutical companies throughout the lifecycle of their products. HERON has expertise and methodologies spanning a wide range of services,...

Award highlights success of innovative strategic partnership at 22nd Annual Partnerships in Clinical Trials conference in Orlando, FL BOSTON, April 24, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced it has been named a recipient of the 2013 "Partnership Pioneers of the Year" award in recognition of its innovative strategic partnership with Pfizer and ICON. Given by the advisory board of the...

Majority of biopharma executives believe Strategic Partnerships positively impact their engagement with CROs BOSTON, April 22, 2013 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today released a new research report called Strategic Partnerships 2013 at the 22(nd) Annual Partnerships in Clinical Trials Conference in Orlando, FL. The report is the first to explore the current outsourcing landscape and the value Strategic...

eClinical leader advances clinical trial management system for utmost flexibility and configurability BOSTON, April 3, 2013 /PRNewswire/ -- Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today released an enhanced version of its comprehensive IMPACT® clinical trial management system (CTMS). Notable features include improved data entry as well as site management and monitoring capabilities. The...

BOSTON, April 2, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter of Fiscal Year 2013 on Tuesday, April 30, 2013 after the close of the stock market. The announcement will be available on PAREXEL's website at www.PAREXEL.com and on the PR Newswire website at www.prnewswire.com. PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Wednesday, May 1, 2013 to discuss the results. To access the...

BOSTON, March 14, 2013 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL) today provided an update and announced the next steps with regard to the Company's share repurchase program. As originally announced on August 8, 2012, the Company's Board of Directors authorized the repurchase of up to $200 million of the Company's common stock. In conjunction with a 10b5-1 open market trading plan that was announced on September 17, 2012, the Company repurchased approximately...

BOSTON, Feb. 28, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Raymond James Investors Conference in Orlando, FL. James Winschel, Sr. Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 9:50 a.m. ET on Tuesday, March 5, 2013. PAREXEL will also be presenting at the Barclays Capital Healthcare Conference in Miami, FL. James Winschel,...

BOSTON, Feb. 20, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Citi Global Healthcare Conference in New York. James Winschel, Sr. Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments at 10:20 a.m. ET on Wednesday, February 27, 2013. A live webcast of the presentation will be available through the "Investors" section of PAREXEL's website at...

BOSTON, Jan. 29, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the second quarter of Fiscal Year 2013, which ended on December 31, 2012. For the three months ended December 31, 2012 consolidated service revenue increased by 26.7% to $422.1 million compared with $333.2 million in the prior year period. Excluding the negative impact from foreign exchange movements in the current quarter of $2.8 million,...